Lampe1: An ENU-Germline Mutation Causing Spontaneous Hepatosteatosis Identified through Targeted Exon-Enrichment and Next-Generation Sequencing by Sheridan, Rachel et al.
Lampe1: An ENU-Germline Mutation Causing
Spontaneous Hepatosteatosis Identified through
Targeted Exon-Enrichment and Next-Generation
Sequencing
Rachel Sheridan
1., Kristin Lampe
2., Shiva Kumar Shanmukhappa
3, Patrick Putnam
4, Mehdi Keddache
4,
Senad Divanovic
2, Jorge Bezerra
5, Kasper Hoebe
2*
1Department of Pathology and Laboratory Medicine, Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio, United States of America, 2Department of Molecular
Immunology, Cincinnati Children’s Hospital Research Foundation, Cincinnati, Ohio, United States of America, 3Division of Comparative Medicine and Pathology, New
England Primate Research Center, Harvard Medical School, Southborough, Massachusetts, United States of America, 4Department of Human Genetics, Cincinnati
Children’s Hospital Research Foundation, Cincinnati, Ohio, United States of America, 5Department of Gastroenterology, Hepatology and Nutrition, Cincinnati Children’s
Hospital Research Foundation, Cincinnati, Ohio, United States of America
Abstract
Using a small scale ENU mutagenesis approach we identified a recessive germline mutant, designated Lampe1 that
exhibited growth retardation and spontaneous hepatosteatosis. Low resolution mapping based on 20 intercrossed Lampe1
mice revealed linkage to a ,14 Mb interval on the distal site of chromosome 11 containing a total of 285 genes. Exons and
50 bp flanking sequences within the critical region were enriched with sequence capture microarrays and subsequently
analyzed by next-generation sequencing. Using this approach 98.1 percent of the targeted DNA was covered with a depth
of 10 or more reads per nucleotide and 3 homozygote mutations were identified. Two mutations represented intronic
nucleotide changes whereas one mutation affected a splice donor site in intron 11–12 of Palmitoyl Acetyl-coenzyme A
oxygenase-1 (Acox1), causing skipping of exon 12. Phenotyping of Acox1
Lampe1 mutants revealed a progression from
hepatosteatosis to steatohepatitis, and ultimately hepatocellular carcinoma. The current approach provides a highly
efficient and affordable method to identify causative mutations induced by ENU mutagenesis and animal models relevant
to human pathology.
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Introduction
Forward genetics has made a significant impact in identifying
genes involved in the host response to pathogens, or that are
involved in the development of spontaneous disease [1]. Recently,
the approach has significantly benefitted from the publically
available mouse genome sequence and the generation of unique
phenotypes through random germline mutagenesis. The latter
serves to expand the number of available phenotypes and allows
for the genetic exploration of biological fields of interest [2,3]. The
alkylating agent N-ethyl-N-nitrosourea (ENU) for instance is a
powerful mutagen that introduces random point mutations mostly
involving ART transversions or ARG transitions [4,5]. With an
estimate of one nucleotide change per million basepairs, ENU is
believed to introduce ,3000 genome-wide nucleotide changes
translating into ,30 heterozygous coding changes per G1 mouse
and ,4 homozygous coding changes per G3 mouse. Even so, the
approach is still considered a laborious undertaking that requires
significant effort in identifying causative mutations. However,
recent developments in sequencing technologies (next-generation
sequencing) are expected to facilitate identification of causative
mutations in ENU germline mice, while at the same time
significantly reducing costs.
Our laboratory applies a small scale ENU mutagenesis program
to identify genetic loci required for normal lymphocyte develop-
ment/function [6,7]. Among G3 germline mutants, we identified a
pedigree that contained 2 female siblings with obvious growth
retardation. The phenotype was named Lampe1 and behaved as a
homozygous recessive trait. Further characterization revealed that
the reduced weight coincided with the development of spontane-
ous microvesicular hepatosteatosis. To establish a chromosomal
location, we applied low resolution mapping using a custom made
359-SNP map and analyzed 20 mice derived from intercrossed
C57BL/6J
Lampe1/129SvJ F1 hybrid mice. The critical interval for
Lampe1 resided on the distal site of chromosome 11, and contained
285 genes. Using high-density long-oligo sequence capture
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including 50 bp flanking sequences and subsequently performed
next-generation sequencing. A total of 3 confirmed homozygous
mutations were identified with a final coverage of 96.2% of
targeted DNA. One mutation represented a splice donor site
mutation within the Palmitoyl Acetyl-coenzyme A oxygenase-1
(Acox-1) gene. Acox1 is expressed in liver and kidney cells and
mediates the first enzymatic step in the peroxisomal fatty acid
beta-oxidation pathway catalyzing the desaturation of acyl-CoAs
to 2-trans-enoyl-CoAs. Similar to previously generated Acox1 null
mice [8,9], the microvesicular hepatosteatosis in Acox1
Lampe1 mice
evolved into steatohepatitis, liver cell regeneration, and ultimately
development of hepatocarcinoma around 1 year of age.
Materials and Methods
Mice and reagents
All experiments were performed according to the US National
Institutes of Health guidelines and were approved by the IACUC
of The Cincinnati Children’s Hospital Medical Center (protocol #
8D01008). C57BL/6J and 129X1/SvJ mice were obtained from
Jackson Laboratory. Acox1
Lampe1 germline mice were generated at
CCHMC through ENU mutagenesis. All mice were housed under
specific pathogen free conditions. ENU Isopac was obtained from
Sigma Chemical Co. Anti-Acox1 rabbit polyclonal antibody
(Santa Cruz Biotechnology) was raised against amino acids 436–
571 of ACOX1 of human origin and cross-reacted with mouse
Acox1. All primers were obtained from Eurofin MWG Operon.
Primers for genotyping of Lampe1 mutants were: forward
AGATTCAAGACAGAGCCGTGCAAG and reverse ACAGA-
GCCAAGGGTCACATCC. For cDNA amplification, forward
primer TTCTCACAGCAGTGGGATTCC and reverse primer
GGGCTTCAAGTGCTTGTAGTAAG were used.
ENU mutagenesis and tissue phenotyping
Six-week-old C57BL/6J male mice were treated with ENU and
subsequently bred to generate G3 germline mice as described
before [10]. Six-week-old G3 animals were analyzed for
developmental/immunological abnormalities and abnormalities
in weight or growth rate. Liver tissue was collected and
immediately fixed in 10% buffered formalin solution overnight,
followed by routine paraffin embedding. Hematoxylin and eosin
staining was performed on 5 mm sections from the paraffin-
embedded tissue blocks for conventional light microscopy analysis.
Selected paraffin blocks of liver tumors were stained for reticulin
(modified Gordon and Sweet method [11], Ventana Medical
Systems, Tucson, Arizona) to assess the integrity of the supporting
reticulin framework of hepatocytes. The remainder of the liver
tissue was snap frozen in liquid nitrogen and stored at 280uC for
future analyses. Morphologic classification of the liver lesions was
performed according to the International Working Party Classi-
fication of nodular lesions of the liver [12].
SNP genotyping and low resolution whole genome
mapping
To establish a critical region for the Lampe1 mutation, we
performed low resolution mapping using a custom designed
genome-wide SNP map with 359 markers completely informative
for C57BL/6J and 129X1/SvJ genetic backgrounds. Genotyping
was performed using the Illumina GoldenGate Assay [13]. Briefly, a
homozygous male Lampe1 mutant was outcrossed to 129X1/SvJ
females. Subsequent hybrid males and females were intercrossed
and 20 offspring were evaluated for concordance between presence
of the phenotype and homozygosity for a SNP marker, and absence
of the phenotype and heterozygosity/homozygosity for the 129X1/
SvJ allele. The LOD (Log Odds Distance) score (F) was calculated
for each marker, and used as an objective index of linkage.
Genomic DNA capture and deep sequencing
Following the establishment of a critical region, a custom 385 K
Roche-NimbleGen SeqCap array was designed to enrich exons,
including 50 bp upstream/downstream sequence, defined in the Mus
musculus NCBI build 37.1 annotation (the region of interest; Figure
S2a). The Nimblegen probe selection algorithm was able to target
98.7% of the region of interest. Areas that could not be targeted were
low copy repeats mostly representing non-coding bases.
Mouse genomic DNA extracted from tail clips was sonicated
and adapters ligated to the fragment ends to prepare a template
library for next-generation sequencing. The library was hybridized
to the custom designed NimbleGen SeqCap arrays for 72 h before
washing away the fragments non-specific to the target area. The
enriched DNA was subsequently sequenced on an Illumina
Genome Analyzer IIx using the paired-end protocol and collecting
40 bases from each read. Read alignment against the mouse
genome was performed using the CASAVA software from
Illumina. For variant identification a post-alignment software
program was developed, designated SeqMate (Putnam and
Keddache, unpublished results), to perform read sequence
visualization and analysis. Specifically, this program combines
the aligned reads with the reference sequence derived from the
NCBI build 37.1 database and computes a distribution of call
quality at each aligned base position. The variants are reported
based on a number of parameters: depth of coverage, proportion
of each base at a given position, and the number of different reads
showing a sequence variation. For the array enrichment of Lampe1
exons, parameters were set to: 106minimum coverage, ignore all
observations with a base quality less than or equal to 25, allow
heterozygotes allelic ratios from 50%/50% to 75%/25% and a
minimum of 3 read relative locations per base must be observed.
Ultimately, identified mutations in the Lampe1 critical region were
confirmed by PCR amplification and Sanger sequencing using an
Applied Biosystems 3730xl DNA Analyzer.
Immunoblotting and immunohistochemistry
Immunoblotting was performed using total liver lysate from
Lampe1 or wildtype C57BL/6J mice. Cell lysis and immunoblot-
ting were performed as described previously [14]. Double
immunostaining with Kupffer cell marker anti-CD68 (Serotec,
Raleigh, NC) and fat stain Oil-red O were performed in frozen
liver tissue to evaluate the presence of lipid droplets within Kupffer
cells using the automated Ventana immunostainer, according to
manufacturer’s recommendation. Appropriate positive and nega-
tive controls were used.
Electron microscopy
Liver tissue of wildtype, heterozygote and homozygote Lampe1
mutants (n=3 animals per group) were fixed overnight by
immersion in cold 3% glutaraldehyde solution prepared in
0.175 M cacodylate buffer followed by brief buffer rinse and
post-fixation with osmium tetroxide for 1–2 hours. The fixed livers
were then processed into LX-112 resin by routine techniques,
stained with 2% (vol/vol) uranyl acetate and lead citrate and
examined on Hitachi 7600 transmission electron microscope.
Statistical analysis
Data were analyzed using the GraphPad Prism4H software
(GraphPad Software, San Diego, CA). The statistical significance
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and standard deviation by Student’s two-tailed test or by ANOVA
followed by Dunnett’s test for three or more groups or as indicated
in the text. All data were considered statistically significant if P
values were ,0.05.
Results
Lampe1: an ENU germline mutant exhibiting growth
retardation and abnormal liver development
Among G3 germline mutants, we identified two 6-week-old
mice from a single pedigree that exhibited reduced weight
compared to their littermates. Both were females and weighed
around 11 to 12 grams, approximately 60–70 percent of normal
weight for 6-week-old C57BL/6J females (Figure 1a). The G1
pedigree was selected for further breeding to establish a colony for
in depth phenotype characterization and genetic analysis. The
mutation was designated Lampe1 and behaved as a strictly recessive
trait. Necropsy of 10-week-old Lampe1 mice revealed a relatively
large liver compared to overall body weight (Figure 1b) and livers
were macroscopically defined by yellow discoloration (Figure 1c).
No other gross abnormalities were observed in Lampe1 mutants
following initial examination. Analysis of blood enzyme levels
revealed significantly increased alanine transaminase and alkaline
phosphatase and a trend for increased aspartate aminotransferase
levels—indicating Lampe1 mice suffer from liver injury (Figure 1d–
f). No significant changes in the levels of total protein, globulin or
albumin were observed between C57BL/6J and Lampe1 hetero-
zygous or homozygous mice (Figure S1a–c). Homozygous Lampe1
mice exhibited a reduced fertility and were maintained as
heterozygous breeders.
Identification of the Lampe1 mutation
To identify the causative mutation in Lampe1 mice we applied a
3 step approach consisting of 1) low resolution mapping, 2) exonic
sequence capture and 3) next-generation sequencing of the
enriched DNA. For low resolution mapping, a homozygous
Lampe1 male was outcrossed to 129X1/SvJ females and subse-
quently F1 hybrid offspring was intercrossed to generate F2
offspring. A total of 20 F2 offspring (5 Lampe1 mutant- and 15
wildtype-phenotypes) were analyzed for both phenotype and
genotype. Genotyping was performed using a custom-made 359-
SNP map distinguishing C57BL/6J and 129X1/SvJ genetic
backgrounds. Coarse mapping revealed a single peak with a
LOD score of ,5.44 for SNPs rs3699056 and rs13481247 located
on the distal end of chromosome 11 (Figure 2a). The entire critical
region consisted of ,14.7 Mb genomic DNA containing 285
annotated genes. The region was defined by proximal SNP
rs6386362 all the way to the distal end of chromosome 11. Using
the UCSC genome browser and the NCBI build 37.1 database
(mus musculus), the genomic coordinates for the region-specific
coding sequences including an additional 50 bp flanking sequence
on both sides of the exons (region of interest; Figure S2a) were
defined and subsequently submitted to NimbleGen for the design
of a capture array. This resulted in the targeting of 2091 exons
covering 690.7 kb of total genomic DNA, of which 98.7 percent
was covered by sequence capture probes (Figure S2a). The
enriched genomic DNA was submitted for next-generation
sequencing and 98.1% of the targeted sequence was covered with
a depth of 10 reads or more. Comparison of the sequence with the
reference sequence derived from the NCBI build 37.1 database
identified a total of 6 homozygous and 2 heterozygous nucleotide
changes within the targeted sequence (Table 1). Subsequently,
each nucleotide variant was amplified by PCR from both C57BL/
6 and Lampe1 genomic DNA and analyzed by conventional Sanger
sequencing. Of the identified nucleotide changes, 3 homozygote
mutations were confirmed (Table 1) and 5 nucleotide changes
were deemed false positives, potentially introduced during the
amplification step following DNA capture. Two of the confirmed
homozygous mutations represented intronic mutations, whereas
one mutation represented a potential splice donor site of the
Palmitoyl Acetyl-coenzyme A oxygenase-1 (Acox1) gene between
exon 12 and 13 (Table 1 and Figure S2b).
The phenotype of Acox1-deficient mice has previously been
reported [8] and the Acox1 gene represented an obvious candidate
gene within the critical region. It is expressed in liver and kidney
cells and is responsible for the first enzymatic step in the fatty acid
beta-oxidation pathway; it catalyzes the desaturation of acyl-CoAs
to 2-trans-enoyl-CoAs. The gene consists of 14 exons and
disruption of the splice donor site within intron 12–13 could
either lead to inclusion of the 131 bp intron in mature Acox1
mRNA, cause the formation of a new cryptic splice site and/or
result in exon skipping (Figure 2b). We therefore assessed mRNA
expression and amplified cDNA generated from C57BL/6J and
Lampe1 liver tissue using primers covering exons 9–14. Gel analysis
revealed a major band with a ,150 bp reduction in size compared
to the wildtype C57BL/6J amplicon in both liver and kidney tissue
(Figure 2c). Subsequent sequencing of cDNA products revealed
deletion of 144 nucleotides from the cDNA amplicon representing
exon 12 of Acox1 (Figure 2b and Figure S2c). Skipping of exon 12
would cause the deletion of 48 amino acids from the Acyl-CoA
oxidase domain at the c-terminal part of Acox1 (Figure 2e). In
addition, a second band of ,780 bps suggested an alternative
splice form was expressed in the liver and kidney of Lampe1 mice.
Subsequent isolation and sequencing of this amplicon revealed the
creation of new splice site within intron 12–13, resulting in the
inclusion of 25 bps of intronic sequence in the Lampe1 transcript
(Figure S2c). Translation of this transcript is predicted to cause a
frameshift and alternative coding at amino acid 577 followed by a
premature stop at amino acid 618 (Figure S2d), thus resulting in
partial deletion of the C-terminal Acyl-CoA oxidase domain.
Immunoblot analysis of Acox1 protein expression in liver cells or
kidney tissue revealed a slightly reduced molecular weight of the
Acox1 protein in Lampe1 mutant cells, consistent with a 48 amino
acid deletion (Figure 2d). Based on the observations, we concluded
that the identified variant causing disruption of the Acox1 splice
donor site was responsible for the development of hepatosteatosis
and growth retardation in Lampe1 mice (from here on designated
Acox1
lampe1 mice).
Hepatic phenotype of Acox1
lampe1 mice
To examine the Acox1
lampe1 phenotype in more detail, we
performed a thorough analysis of the liver histology and
ultrastructure at various ages. At 8 weeks, the liver of Acox1
lampe1
mice showed extensive microvesicular steatosis involving most of
the hepatic lobule with sparing of periportal hepatocytes
(Figure 3b–d). This striking zonal pattern of steatosis persisted at
2, 3 and 4 month-old mice (Figure 4a–c). At 6 months, the liver
parenchyma contained areas with steatotic hepatocytes (Figure 4d)
as well as multiple lobules showing complete resolution of steatosis
(Figure 4e), except for the presence of distended Kupffer cells
containing lipid material (Figure 4e). Double immunostaining with
anti-CD68 antibody and Oil Red O performed on frozen liver
samples confirmed the presence of fat droplets within the
sinusoidal Kupffer cells (Figure 5a–c).
Ultrastructurally, Acox1
lampe1 livers revealed numerous lipid
vacuoles of varying sizes within the cytoplasm of zones 2 and 3
hepatocytes, displacing most of the cytoplasmic organelles
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diminished numbers of peroxisomes. In contrast, the hepatocytes
immediately adjacent to the fatty area demonstrated a relatively
higher amount of peroxisomes, which formed discreteclusters inthe
cytoplasm (Figure 6c). Away from the fatty area, the distribution of
peroxisomes was heterogeneous, with patchy clusters observed in
some of the hepatocytes around zone 1 (Figure 6d). The
mitochondria were swollen with a markedly hypodense matrix.
Laminated material (Figure 6e) and lipid vacuoles were seen within
the mitochondrial membranes or matrix.
The resolution of poor weight gain observed in young Acox1
lampe1
mice raised the possibility that the liver injury resolved. To address
this possibility, we performed a detailed histological survey of the
mouse liver well into adulthood. We found partial resolution of the
hepatic steatosis (Figures 4e and 7a), accompanied by lobular
inflammatory infiltrates, comprised of numerous clusters of
lymphocytes and Kupffer cells (Figure 7b). At necropsy, the livers
of 15 month-old mice were significantly enlarged and contained
distinct nodular lesions with slightly different color from the
surrounding hepatic parenchyma. On histology, the lobular
architecture was disrupted by almost complete replacement of the
parenchyma by nodules of varying sizes (Figure 7c). The nodules
consisted ofeosinophilicand/orbasophilichepatocyteswith focalor
diffuse dysplastic changes and increased cell density (Figure 7d).
Microscopic foci of large and small cell change were scattered
throughout the parenchyma. Histological features of hepatocellular
carcinoma (HCC) such as increased cellularity, liver cell plate
thickening and expansile or invasive growth patterns occurred in
multiple areas and intermingled indiscernibly with the dysplastic
foci (Figures 7e). HCC showed solid, trabecular and sinusoidal
patterns and focal to complete loss of the reticulin network
supporting the diagnosis of malignant transformation (Figure 7f).
Overall, Acox1
lampe1 mice present a similar phenotype as
previously described for Acox1 knockout mice [8] and exhibit
hepatosteatosis at an early stage that slowly evolves into hepatos-
teatitis and induction of liver cell regeneration, ultimately driving
the development of hepatocarcinoma around 1-year of age.
Discussion
The rate-limiting step in ENU mutagenesis has long been the
identification of causative mutations. Here we report a cost-
Figure 1. Identification and characterization of Lampe1 ENU germline mutants. (a) Reduced growth of homozygote Lampe1 male and
female mice compared to heterozygote littermates. (b) Relative liver weight in homozygote/heterozygote Lampe1 mutants and wildtype C57BL/6J
mice. (c) Macroscopic view of livers from 10-week-old homozygote/heterozygote Lampe1 mutants and C57BL/6J wildtype mice. (d–f) Blood levels of
ALT, AP and AST liver enzymes measured in 10-week-old Lampe1 homozygote/heterozygote mutants and C57BL/6J mice. All experiments were
performed using at least n=3 per group. ***=P,0.001.
doi:10.1371/journal.pone.0021979.g001
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variants. Specifically, we targeted the Lampe1 locus—an ENU
germline mutant exhibiting growth retardation and spontaneous
hepatosteatosis, evolving to steatohepatitis and hepatocellular
carcinoma. We performed low resolution mapping based on a
limited number of meioses resulting in the identification of a
,14 Mb critical region. Subsequently we applied targeted exon
enrichment—with the inclusion of 50 bp proximal/distal flanking
sequence for all exons—and analyzed the enriched DNA using
next-generation sequencing technology. The approach effectively
identified a donor splice site mutation in the Palmitoyl Acetyl-
coenzyme A oxygenase-1 (Acox1) gene that was responsible for the
Figure 2. The Lampe1 phenotype is caused by a splice site mutation in Acox1 resulting in deletion of 48 amino-acids from the C-
terminal oxidase domain. (a) Low-resolution mapping of the Lampe1 mutation based on twenty mice and a panel of 359 SNPs covering the entire
genome. The Lampe1 phenotype was linked to the distal site of chromosome 11. (b,c) The ARC splice site mutation results in skipping of exon 12
thereby removing 144 nucleotides (b) as determined by amplification and sequencing of the cDNA region covering exon 9–14 (c). (d,e) At the
protein level, the mutation causes the deletion of 48 amino-acids from the C-terminal acyl-CoA oxidase C domain (e) resulting in a slightly reduced
molecular weight (69.3 kDa instead of a 74.6 kDa protein) (d). Similar differences in molecular weight were observed for liver and kidney tissue.
doi:10.1371/journal.pone.0021979.g002
Table 1. Mutations identified in the Lampe1 critical region.
Gene affected Relative Position Position chrom. 11 Type of mutation Depth* Ref
* Confirmed POI* observation
Dnaic2 472 114605790 intron 460 A no G (100)
Dnaic2 473 114605791 intron 370 G no A (100)
Sumo2 295 115395864 intron 216 A no A (72)/C (27)
Acox1 633 116035943 splice site 179 A yes G (100)
Evpl 849 116086932 intron 58 A no C (52)/A (47)
Gaa 1287 119142715 intron 38 T yes A (100)
Hgf 582 120333206 intron 421 G no A (100)
Hgf 1656 120339613 intron 824 T yes C (99)
*Depth: the number of reads for the specified nucleotide; Ref: reference nucleotide as annotated in the NCBI build 37.1 database; POI, Point Of Interest.
doi:10.1371/journal.pone.0021979.t001
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eliminated the necessity for fine-mapping—a laborious, time
consuming and relative expensive process related to forward
genetics and ENU mutagenesis. The coverage of targeted DNA
for the Lampe1 critical region was exceptional, with 98.1% of the
targeted region being sequenced with a minimal depth of 10. This
Figure 3. Histopathology of the liver. (a,b) Hematoxylin and eosin staining of control (a) and Acox1
lampe1-mutant (b) liver at 2 months showing
severe microvesicular steatosis affecting pericentral and midzone hepatocytes (arrows) with relative sparing of periportal hepatocytes. (c,d) Oil-red O
staining reveals fat accumulation in a similar zonal distribution in Acox1
lampe1 livers (d), while no staining is observed in livers from control mice (c).
(a–d: 1006magnification).
doi:10.1371/journal.pone.0021979.g003
Figure 4. Persistent liver injury in Acox1
lampe1 mice. (a–c) A zonal pattern of steatosis (arrows) with sparing of periportal hepatocytes is
observed in Acox1
lampe1 livers at 2–6 months of age. At 6 months, the distribution of fat is highly heterogeneous with some residual areas of steatosis
(d; arrows), admixed with large zones that are devoid of fat and predominantly composed of hepatocytes with deeply eosinophilic cytoplasm(e). (a),
2 months; (b), 3 months; (c), 4 months; (d) and (e), 6 months. Hematoxylin and eosin; 4006magnification.
doi:10.1371/journal.pone.0021979.g004
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lampe1 mice. (a) Oil-red O stain demonstrates the presence of intracytoplasmic lipid
vacuoles in hepatocytes and Kupffer cells. (b) Double immunostaining with Oil-Red O and anti-CD68 confirms the location of the fat droplets in the
cytoplasm of sinusoidal Kupffer cells. (c) CD68 highlights an enlarged Kupffer cell with abundant vacuolated cytoplasm. Magnification 10006.
doi:10.1371/journal.pone.0021979.g005
Figure 6. Ultrastructural changes in Acox1
lampe1 livers. Electron micrograph from the liver of an 8-week-old Acox1
lampe1 mouse (b–e) compared
to age-matched control (a, f). The appearance of normal hepatocytes from an 8-week-old wild-type mouse (a) contrasts with hepatocytes from
Acox1
lampe1 liver, which show small and large lipid droplets displacing the cytoplasmic organelles (b). Increased number of peroxisomes in
hepatocytes immediately adjacent to the steatosis, often arranged in clusters (c, arrows). In areas of the parenchyma away from the fat, only
occasional clusters are observed in periportally located hepatocytes in a patchy distribution (d, arrows). The mitochondria in Acox1
lampe1 hepatocytes
show marked enlargement with swelling and decreased matrix density and presence of laminated material (e, arrow) compared to control mice (f).
doi:10.1371/journal.pone.0021979.g006
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that a relatively small genomic interval was targeted (690.7 kb of
targeted DNA). The Nimblegen array used in this study has
384,000 probes and a capacity to capture up to 5 Mb of DNA
sequence. This means that the tiling across the target region was
approximately 1 probe every 1 or 2 bases on average. This optimal
capture design, combined with the large number of reads
generated (average coverage depth of 4536over the target region)
were critical elements that allowed us to obtain 106coverage on
98.1% of the target region.
Although the size and gene density of a critical region may vary
somewhat between ENU germline mutants, we anticipate that the
obtained sequence coverage can generally be reproduced with a
similar probe design and total number of reads generated. In
addition, the enrichment capacity of 2.1 M arrays captures
,30 Mb of targeted sequence, allowing for the analysis of the
entire mouse exome. Nonetheless, causality (i.e. through linkage
analysis or genetic confirmation) will remain an essential aspect of
forward genetics.
The effective identification of genomic nucleotide changes also
expands the possibilities in (immune)phenotyping. In many
instances, phenotypes are lost or significantly influenced by
modifier loci located on outcross strains carrying a high degree
of genetic variation. For example, the genetic dissection of NK cell
function has proven challenging in our laboratory because of the
large variation in NK cell ligands/receptors existing on different
mouse backgrounds (Hoebe, unpublished results). The current
approach avoids fine mapping and allows for the exploration of
phenotypes that are more subtle and can be traced following the
outcross to strains with minimal genetic variation (e.g. the C57BL/
6J and C57BL/10J strains). Thus the ability to effectively target
large genomic intervals not only facilitates mutation discovery, but
also expands the number of phenotypes that can be explored.
Interestingly, ENU has been described as a powerful mutagen that
at optimal doses can induce about one base-pair change per
million base-pairs of genomic DNA [15]. Here we identified and
confirmed 3 base-pair changes in 690 kb of sequenced DNA,
suggesting a higher mutation frequency induced by ENU than
previously estimated. Further analysis of large areas of genomic
DNA using next-generation sequencing should ultimately provide
a better idea of the exact mutation frequency for ENU in mice.
The pathogenesis observed in Acox1
lampe1 mice largely resembles
the pathogenesis observed in Acox1 null mice as previously
published by Reddy’s group [8,9,16]. The latter presented growth
retardation, severe microvesicular hepatic steatosis and sustained
activation of peroxisome proliferator-activated receptor-a
(PPARa) [8,9,16]. Acox1 is expressed as a 72 kDa precursor
protein that enters the peroxisome via the C-terminal Ser-Lys-
Leu-related tripeptide target signal [17]. Within the peroxisome,
Acox1 is cleaved by the protease trypsin domain-containing 1
(Tysdn1), resulting into a 50 kDa N-terminal and a 22 kDa C-
terminal subunit ultimately generating heterodimeric complexes
comprised of all three subunits [17,18]. The Lampe1 mutation
affects the C-terminal domain of Acox1 containing the Acetyl-
CoA oxidase domain—an essential domain for enzyme activity.
The 48 amino acid deletion, however, does not affect the C-
terminal signal peptide (SKL) nor does it affect the Tysdn1-specific
cleavage site, suggesting normal localization and processing of the
mutant Acox1 protein in the peroxisome may still occur. Indeed,
immunoblot analysis reveals a quantitative similar expression of
Acox1, albeit with a reduced molecular weight in liver and kidney
of Acox1
lampe1 mice. Although we have not performed enzymatic
activity assays to confirm the loss of Acox1 function in Lampe1
mutant mice, the 48 amino-acid deletion from the Acetyl-CoA
oxidase domain is likely to render the protein functionally deficient
and cause a phenotype similar to the previously reported Acox1
null mice. Nonetheless, subtle differences seem apparent between
both mouse models. First of all, the distribution of microvesicular
fatty metamorphosis in 2-month-old Acox1
lampe1 livers is zonal and
observed in zones 2 and 3 but not zone 1, whereas Fan et al
reported fatty changes in all hepatocytes irrespective of their
distribution in the liver of Acox1
2/2 mice at similar age [8,9].
Notably, we observed a more severe and uniform fatty
metamorphosis in the liver following the outcross of the Lampe1
Figure 7. Evolution of steatosis to steatohepatitis and neoplasia. (a) Histology of the liver of a 4 month-old Acox1
lampe1 mouse showing fat
accumulation in a zonal distribution around the central veins (magnification 2006) and (b) scattered foci of lobular inflammation with aggregates of
macrophages at 4 months (magnification 4006). (c) At 12 months, the liver architecture is markedly disrupted by expansile nodules replacing most of
the parenchyma (magnification 2006). (d) Foci of dysplastic hepatocytes and dysplastic nodules were present throughout the liver and some of the
nodules contained areas of frank hepatocellular carcinoma (e), with loss of reticulin fibers (f). Hematoxylin and eosin (a–e) and reticulin (f) stain. 6D–F
4006magnifications.
doi:10.1371/journal.pone.0021979.g007
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suggesting that modifier loci on the 129X1/SvJ or C57BL/6J to
some extent influence the degree of hepatosteatosis.
Acox1 is essential for b-oxidation of very-long chain fatty acyl-
CoA and arachidonic acid metabolites such as 8(S)-hydroxy-
eicosatetraenoic acid and leukotriene B4 (LTB4). In the absence of
functional Acox1, these lipid metabolites accumulate and act as
natural ligands for the nuclear receptor PPARa [19,20,21],
initiating a unique transcriptional program following heterodi-
meric association of PPARa with nuclear retinoid X receptor
(RXR) [22]. Ultimately, this complex induces a select set of genes
encoding the peroxisomal b-oxidation system, including Acox1
but also enzymes such as cytochrome P450 4A isoforms (CYP4A1
and CYP4A3) [23,24]. The latter metabolize long-chain fatty acids
via the v-oxidation pathway. In the absence of functional Acox1,
this pathway becomes an important metabolic pathway for long-
chain fatty acids, resulting in accumulation of toxic dicarboxilic
acids (DCAs) causing mitochondrial damage [21,25]. In addition,
the dramatic increase in enzyme expression related to lipid
oxidation coincides with high levels of reactive oxygen species such
as hydrogen peroxide, ultimately causing cell death, regenerative
cell proliferation and hepatocarcinogenesis [21]. Indeed, com-
pound homozygous PPARa
2/2, Acox1
2/2 mice lack increased
peroxisomal proliferation and exhibit reduced steatosis and liver
cell proliferation [26], thus verifying the essential role of PPARa in
the pathogenesis of Acox1-deficient mice. Although in our
Acox1
lampe1 model we have not directly measured the activation
of PPARa and expression of CYP450 enzymes, the morphologic
changes in the liver of Acox1
lampe1 mice were similar to the
previously published Acox1-null mice by Reddy’s group. Finally,
the increased number of peroxisomes in hepatocytes was a
common feature in both Acox1
2/2 and Acox1
lampe1 mice. In
addition, stress changes in the mitochondria were prevalent in
Acox1
lampe1 mice.
Recent epidemiological reports suggest that obesity significantly
increases the risk of hepatocellular carcinoma in humans [27,28].
Obesity is associated with simple steatosis (60%), nonalcoholic
steatohepatitis (25%) whereas 3% to 5% of obese people exhibit
liver cirrhosis [29]. Steatosis is associated with increased levels of
ROS and the induction of low level inflammatory response
including the release of proinflammatory cytokines such TNFa
[29]. A report by Park et al suggests that low-level inflammation,
specifically the activation of STAT3 via cytokines such as IL-6, is a
requirement for development of hepatocellular carcinoma in
mouse models with dietary or genetic obesity [30]. Currently, the
molecular basis for (sterile) low level inflammation in Acox1-
deficient mice or for that matter in the context of obesity is poorly
defined. An important trigger of inflammation may be derived
from the excessive cell death—possibly due to CYP4A-mediated
ROS production and DCA-release—observed in Acox1-deficient
mice. This may induce further release of lipids and other
components sensed by innate immune receptors ultimately causing
steatohepatitis, cell proliferation and hepatocellular carcinoma. A
large number of studies have reported the induction of
proinflammatory cytokines following exposure of dendritic cells
or macrophages to cell death [31,32,33,34]. The regulatory
pathways and innate receptors involved in mediating inflamma-
tion via cell death have been poorly defined particularly in the
context of dying cells with excessive lipid accumulation as
observed in Acox1-deficient mice. Thus Acox1
lampe1 mice may
present a unique model to further dissect the (sterile) inflammatory
pathways that drive liver regeneration and ultimately hepatocel-
lular carcinoma.
Supporting Information
Figure S1 Protein (a), globulin (b) and albumin (c) levels
measured in blood from 10-week-old Lampe1 homozygote/
heterozygote mutants or C57BL/6J mice. (n=3 per group).
(TIF)
Figure S2 Targeting the Lampe1 critical region for exon
enrichment using high-density long-oligo arrays. (a) Exons
including 50 bp upstream/downstream sequence were defined
based on the Mus musculus NCBI build 37.1 database (primary
target region) and submitted for enrichment. The Nimblegen
probe selection algorithm captured 98.7% of targeted sequence
with 1.3% being excluded based on low copy repeat sequence
mostly representing non-coding sequence. (b) The Lampe1
mutation represents a splice donor site mutation in intron 12–13
of Acox1. (c) Alignment of Acox1 cDNA from wildtype and
Acox1
lampe1 mutant mice, for the major and minor splice forms, as
determined by sequencing. (d) Predicted c-terminal protein
sequence of the minor splice form of Acox1
lampe1.
(TIF)
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